In this week’s Homerun Slides continuing our series from Dr. Stanley Schwartz, we cover topics including the Benefits of Combined Treatment (Pharmacotherapy and Lifestyle Modification), a demonstation of how Obesity Requires Long-Term Care, and information on how Roux-en-Y surgery restores the incretin effect…
Read More »Yearly Archives: 2014
Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #43: Pharmacotherapy of Type 2 Diabetes, Part 2
Richard S. Beaser, MD This week’s excerpt covers the following topics: The mechanism of action for antidiabetes medications Which medications improve insulin action Which meds slow gastric absorption Which meds increase insulin secretion Which meds increase the effect of incretins How to compare diabetes meds
Read More »Actos Generic Available Shortly from Lupin
Actos Generic Available Shortly from Lupin – Lupin has announced that it received final approval from the FDA for pioglitazone tablets USP in 15-mg, 30-mg and 45-mg strengths. The product is the generic version of Actos tablets from Takeda Pharmaceuticals. Albiglutide, Weekly Injectable GLP-1 Drug, Receives FDA Approval – (See this week’s Item #6.)
Read More »Great Low Carb Pizza Crust 9″
Great Low Carb Pizza Crust 9" This 8 oz. 9" pizza crust from the Great Low Carb Bread Company has just 4- 2 net carb servings. Great tasting and already par baked so just pile your toppings on and bake for 5 minutes in an oven or toaster oven at 350 …
Read More »Editor’s Note, GLP-1 Analog Special Edition, April 2014
When we sit down with our patients to talk about starting on GLP-1 analogs, we usually explain the main ways that they work. These are usually decreased glucagon release, less glucose dumping from the liver, increased and faster insulin secretion, slowing of gastric emptying and increased satiety. However there is …
Read More »The Effects of GLP-1 Analogs in the Portal System
Under normal conditions, the liver plays a critical role in disposing of orally or enterally delivered carbohydrate and therefore in limiting postprandial hyperglycemia. We often think that this response involves only a decrease in hepatic glucose production however there are many studies showing that there is also a stimulation of …
Read More »Diabetes Expenses Have Decreased but Still High
Out-of-pocket expenses for diabetes treatment have gone down for many U.S. patients over the past decade, according to a new study. But nearly a quarter of people with diabetes still face high expenses. In particular, (out-of-pocket) expenses declined in the people with public insurance and in people with low income …
Read More »Obesity Blamed for Rise in Diabetes
An ‘alarming’ rise in obesity has contributed to a dramatic increase in the prevalence of diabetes in the U.S, according to a new study. Researchers examined the prevalence of diabetes, prediabetes, and glycemic control in 43,439 adults in the NHANES study from 1988 to 1994 and 1999 to 2010. The …
Read More »In Two Decades, Diabetes Doubled
The authors of a new study found that the rise in diabetes from 5.5% to 9.3% of the U.S. population over the last 20 years paralleled the growing rate of obesity in America. Better screening tools such as the HbA1c diagnostic test have also helped physicians identify more diabetes cases, …
Read More »Renal Failure Associated with Depression in Adults with Diabetes
Diabetic patients who are depressed may be at an increased risk for developing end-stage renal disease….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.